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The aim of this study was to evaluate the effect of enamel matrix derivate (EMD) with combination of composite
bovine-derivate xenograft on the periodontal regeneration in the interproximal periodontal defect model. The inter-
proximal periodontal defects (IPDs) were surgically prepared between the first and second maxillary premolar, and
the second and third maxillary premolar in four beagle dogs. EMD, collagenized bovine hydroxyapatite (CBHA),
combination of two material, and sham surgery were allocated for each IPD. After eight weeks, the animals were
sacrificed and the defects were analyzed by radiographic, histologic, and histometric methods. Regenerated woven
bone was observed and cementoid was created along the adjacent root surfaces with proliferation of cementoblasts
in every group. In the combination of EMD and CBHA group, Sharpey’s fiber was observed beyond the crest of
new bone and along the newly formed cementum, and apical migration of junctional epithelium appeared to be
blocked by new cementum. In the BC and EMD+CBHA groups, the residual bovine hydroxyapatite particles were
found in the periodontal defect. No direct contact was observed between residual particles and tooth surfaces. No
remarkable difference was found between the histometric results among the groups. Within the limitation of this
study, EMD, CBHA, and combination of two materials showed similar periodontal regeneration in the interproximal
periodontal defect model. Further investigation on combination with barrier membrane may be required for
improvement of the regenerative potential.
Key words: enamel matrix proteins, xenograft bioprosthesis, periodontal disease, regeneration
Introduction
or periodontal regeneration, guided tissue regeneration
(GTR) has been widely used with the concept of selective
repopulation of periodontal ligament cells.1,2) Histologically GTR
has shown the formation of new cementum, periodontal liga-
ment, and bone in animal studies in various defect types.3-9)
Human studies have also reported regeneration of cementum
and periodontal ligament in histologic analysis.1,2,10,11) Clinical
attachment gain and probing depth reduction were observed
following GTR in human clinical trials.12-16) Therefore, GTR is
considered as a reliable method for the regeneration of peri-
odontal tissue.
However, alternative approaches for periodontal regenera-
tion have been investigated for avoidance of complication and
difficulty of GTR. Major complications of GTR include exposure
of barrier membranes. When the membrane was exposed, cell
occlusion is impaired and epithelial downgrowth is not
blocked perfectly. In addition, GTR requires advanced flap
management and suture techniques. The outcomes of GTR
are thus often affected by technique sensitivity.
Enamel matrix derivate (EMD) has been introduced to facil-
itate the periodontal regeneration. Amelogenin is a protein
that plays an important role in the development of enamel
structure. EMD refers to purified hydrophobic amelogenins,17)
which promotes periodontal regeneration by mimicking the
development of periodontium.18) For the vehicle of EMD pro-
pylene glycol alginate (PGA) showed superior results to other
alternatives such as hydroxyethyl cellulose.19) 
EMD showed formation of new cementum, periodontal lig-
ament, and bone when applied in animal intrabony,18) furca-
tion,20) and dehiscence type defects.21,22) In human clinical
studies Emdogain showed bone regeneration, clinical attach-
ment gain, and probing depth reduction in intrabony
defects23-27) and class II furcation defects.28,29)
Lack of space maintenance, however, prevents the peri-
odontal regeneration by EMD in non-contained defects. The
amount of radiographic and clinical gain followed by applica-
tion of EMD is significantly less in the 1-wall intrabony defects
than 2- or 3-wall defects.30) In class III furcation defects EMD
failed to achieve complete healing of the defect and there was
no significant difference in clinical outcomes between EMD
and GTR.31)
Combination of bone material with EMD has been con-
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ducted for improvement of space maintenance and regenera-
tion potentials. The effectiveness of combination of bone
material with EMD shows inconsistent outcomes and needs
more investigation. For space maintenance particulated bone
material was used in combination with EMD. Bovine hydroxya-
patite (BH) was widely used due to superior biocompatibility.
In vitro EMD enhanced the cell activity on residual bovine
bone particles.32) However, the effectiveness of combination
remained still controversial in human studies.33-37) In animal
intrabony defects EMD combined with BH enhanced the for-
mation of new connective tissue and bone,38) and similar
results were shown in a human study.39) However, other stud-
ies failed to show that combination of EMD with other agents
can improve the final results.37,40,41)
A collagenized bovine hydroxyapatite (CBHA) was also in-
troduced in periodontal regeneration. CBHA consists of mainly
deproteinized bovine cancellous bone granules (90%), which
are embedded in highly purified collagen matrix (10%). In
intrabony defects CBHA itself showed superior clinical gain in
human clinical studies.42-44) New bone, cementum, and peri-
odontal ligament were observed in histologic analysis of
human intrabony defects.45) Grafted in extraction sockets,
CBHA has exhibited less shrinkage of residual ridge,46,47)
which implies the potential of preservation of residual ridge.
However, regenerative potential of combination therapy with
CBHA and EMD has not been clarified.
The aim of this study was to evaluate the effect of EMD
with application of CBHA on the periodontal regeneration in
the interproximal periodontal defect model.
Materials and Method
Animals
Four 15-months-old beagle dogs with healthy periodontium,
each weighing 10-15 kg, were used. Animal selection, man-
agement, preparation, and the surgical protocol followed the
protocol that was approved by the Institutional Animal Care
and Use Committee, Yonsei Medical Center, Seoul, Korea.
Surgical protocol
The surgical procedure was performed under general anes-
thesia with subcutaneous injection of atrophine 0.05 mg/kg
and intravenous injection of compound of xylazine (Rom-
pun®, Bayer Korea, Seoul, Korea) 2 mg/kg and ketamine
hydrochloride (Ketalar®, Yuhan Co., Seoul, Korea) 10 mg/kg.
After intubated, 2% enflurane was administered and the disin-
fection of surgical sites was performed. Routine dental infiltra-
tion anesthesia was performed with 2% lidocaine hydrochloride
including epinephrine 1:100,000 (Kwangmyung Pharm., Seoul,
Korea). Mucoperiosteal flap was reflected after a crevicular
and vertical incision at the maxillary premolar area.
The interproximal periodontal defects (IPDs) were surgically
prepared in each side between the first and second maxillary
premolar (P1 and P2), and the second and third maxillary pre-
molar (P2 and P3) with a fissure bur and a chisel with contin-
uous saline irrigation for prevention of overheating. The width
of the defect was 3 mm, measured from the center of the
defect to buccal and palatal bone. The apical notch was cre-
ated on the roots of the teeth adjacent to the defects to ensure
the height of the defect to be 5 mm, measured from the apical
reference notch to the cementoenamel junction (Figure 1). 
The root planning of teeth were performed with root plan-
ning bur and Gracey curettes to remove old cementum. One
of following material was randomly allocated for each IPD:
Bio-oss Collagen® (Geistlich Sons Ltd., Wolhusen, Switzer-
land), Emdogain® (Straumann, Basel, Switzerland), combina-
tion of both materials, and sham surgery. After application of
material, the flap was positioned coronally and primary ten-
sion-free wound closure was accomplished. The flap was
sutured with 5-0 resorbable suture material (Polyglactin 910,
braided absorbable suture, Ethicon, Johnson & Johnson Int.,
Edinburgh, U.K.) with interrupted suture. 
Post-surgery management
Post-surgery management included intravenous injection of
antibiotics (Cefazoline Sodium 20 mg/kg, Yuhan Co., Seoul,
Korea) and topical application of chlorhexidine solution (Hexa-
medine 0.2%, Bukwang pharmaceutical Co., Seoul, Korea)
daily for the prevention of infection. The sutures were removed
at approximately 10 days post-surgery. The animals were euth-
anized after 8 weeks following the surgery by intravenous
injection of anesthesia drug overdose.
Histologic processing and radiographic analysis
Block sections including segments of the defects at the sur-
gical sites were dissected at sacrifice. The sections were fixed
in 10% buffered formalin for ten days and rinsed with water.
Then the blocks were scanned with a micro-CT (SkyScan
1072®, SkyScan, Aartselaar, Belgium) at a resolution of 35 lm
(100 kV, 100 µA). The scanned data were converted into a
Figure 1. The interproximal periodontal defect (IPD) prepared
between maxillary premolars.
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Digital Imaging and Communications in Medicine (DICOM) for-
mat and the surgical sites were three-dimensionally recon-
structed with OnDemand 3D® software (Cybermed, Seoul,
Korea). The residual material was selected in each axial cross
section, and combined into red-tone in 3-D reconstruction view.
Histologic analysis
The sections were decalcified in 5% formic acid for 2 weeks
after rinsed in sterile water, and they were dehydrated in a
graded ethanol series and embedded in paraffin. Serial sec-
tions, 5 µm thick, were cut in a mesial-distal direction at inter-
vals of 80 µm. Histologic specimens were observed under a
light microscope (LEICA DM-LB, LEICA, WETZLAR, Germany)
for evaluation of soft and hard tissue healing patterns, which
include the degree of inflammation, bone and attachment gain.
Histometric analysis
Following parameters were analyzed by histometric analysis
(Figure 2):
• Defect height (DH): distance from the cemento-enamel
junction (CEJ) to the apical reference notch
• Long junctional epithelial attachment (LJE): distance from
the CEJ to the apical extension of the junctional epithelium
• Connective tissue attachment (CTA): distance from the api-
cal extension of the junctional epithelium to the coronal exten-
sion of new cementum
• Cementum regeneration (CR): distance from the coronal
extension of new cementum or cementum-like substance to
the apical reference notch
• Bone regeneration (BR): distance from the apical refer-
ence notch to the coronal extension of newly formed bone
Statistical analysis
The means and standard deviations of the measurements
were analyzed descriptively for each group.
Results
Clinical observations and histologic analysis
The wound healing of defects was clinically uneventful
except one defect. On the right side of dog #3, the sutures
were loosened after the surgery and material was lost.
In common, regenerated woven bone was observed, and
cementoid was created along the adjacent root surfaces with
proliferation of cementoblasts. In some specimens, root resorp-
tion and associated osteoclasts were observed. In CBHA and
EMD+CBHA groups, the residual bovine bone particles were
found in the periodontal defect. No direct contact was
Figure 2. The schematic diagram of histometric measurement
parameters. DH: Defect height; LJE: Long junctional epithe-
lium; CTA: Connective tissue attachment; CR: Cementum re-
generation; BR: Bone regeneration.
Figure 3. Histologic analysis (magnification × 40). New bone was formed beyond the bottom of the apical notch (arrows). Migra-
tion of junctional epithelium (arrowheads), connective tissue and vascularization was observed. Residual material (asterisks) was
shown in CBHA and EMD+CBHA groups. (a) EMD+CBHA (b) EMD (c) CBHA (d) Control.
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observed between residual particles and tooth surfaces. No
remarkable difference was found between the occurrences of
root resorption among the groups (Figure 3).
In Masson’s trichrome stain, Sharpey’s fiber was embedded
into newly formed cementum. In EMD+CBHA groups,
Sharpey’s fiber was observed beyond the crest of new bone
and along the newly formed cementum, and apical migration
of junctional epithelium appeared to be blocked by new
cementum (Figure 4). In CBHA groups, residual material was
observed without direct fibrous encapsulation or similar struc-
tures. Sharpey’s fiber was embedded into newly formed
cementum, and inflammatory reaction or other adverse effects
were not observed (Figure 5). Regenerated bone and cementum
were observed in common including EMD group (Figure 6).
Histometric analysis
Table 1 shows the histometric results of DH, LJE, CTA, CR,
and BR. Neither difference nor tendency was observed in any
parameters among groups. 
Radiographic analysis
Residual material was color-coded in three-dimensional re-
construction view. No root resorption was observed in any
groups and new bone was formed beyond the bottom notch
of the defect, which enhances the histologic findings. In every
defect where CBHA was applied with our without EMD, resid-
ual material was observed in the interproximal defect (Figure 7).
Discussion
This study has shown the periodontal regeneration of com-
bination therapy using EMD with CBHA in the periodontal
interproximal defect model. All groups exhibited similar regen-
eration pattern and failed to reveal any differences when EMD
and CBHA were combined.
The regenerative potential depends on the configuration of
the defects. Previously, intrabony defects have been most in-
vestigated to assess the effect of EMD. The potential of regen-
eration depends on the number of bony walls because of
wound stability and vascularization.48,49) In contained defects
Figure 4. Histologic finding in EMD+CBHA group. Masson’s
trichrome stain (magnification × 400) (a) New cementum (NC)
was formed along the root surface, and Sharpey’s fiber (SF) was
embedded into the newly formed cementum. Apical migra-
tion of junctional epithelium appeared to be blocked by NC.
(b) New bone was formed, and inflammatory reaction was not
observed.
Figure 5. Histologic finding in CBHA group. Masson’s trichrome
stain (a) New cementum (NC) was formed along the root sur-
face, and Sharpey’s fiber (SF) was embedded into the newly
formed cementum (magnification × 400). (b) Residual material
(RM) was observed, without direct fibrous encapsulation or sim-
ilar structures. Inflammatory reaction or other adverse effects
were not observed (magnification × 200).
Figure 6. Histologic finding in EMD group. Masson’s trichrome
stain (a) New bone (NB) formation was observed, and new
cementum (NC) was formed along the root surface (maginifi-
cation × 40). (b) Sharpey’s fiber (SF) was embedded into the
newly formed cementum (magnification × 400).
Table 1. Histometric analysis
EMD 
(n = 2)
EMD+Bio-oss
(n = 2)
Bio-Oss
(n = 5)
Control
(n = 4)
LJE 1.22 ± 0.32 1.93 ± 0.37 1.82 ± 0.72 1.10 ± 0.24
CTA 0.39 ± 0.14 0.37 ± 0.35 0.23 ± 0.20 0.36 ± 0.30
CR 2.92 ± 0.23 2.26 ± 0.31 2.75 ± 0.74 2.92 ± 0.51
BR 1.75 ± 0.04 1.80 ± 0.09 2.06 ± 0.69 1.81 ± 0.15
DH 4.53 ± 0.25 4.55 ± 0.33 4.81 ± 0.18 4.38 ± 0.35
EMD, enamel matrix derivate; LJE, long junctional epithelial attach-
ment; CTA, connective tissue attachment; CR, cementum regenera-
tion; BR, bone regeneration; DH, defect height.
150 Kyu An Lee, Hyun-Chang Lim, Min-Soo Kim, Jung-Seok Lee, Seong-Ho Choi, and Ui-Won Jung
Biomaterials Research 2013
such as 3-wall defects EMD alone showed significantly supe-
rior periodontal regeneration compared with control group
and comparable regeneration with GTR procedure. However,
non-contained defects have not shown consistent results.
While in some studies EMD showed significantly higher peri-
odontal regeneration than control in 1-wall and 2-wall
defects,24,50-52) other studies failed to show significant improve-
ment of the probing depth and clinical attachment gain.30,53)
Histologic analysis in humans showed the evidence of peri-
odontal regeneration in deep intrabony pockets but on an
inconsistent basis.54) Other types of non-contained defects
have yielded much less favorable regeneration than in the
intrabony defects. In the supraalveolar defects, the regenera-
tion of new cementum was observed when EMD was applied
in rats, but the authors failed to show the significant improve-
ment over the control.55) In the dehiscence defects of beagle
dogs, new bone formation was limited in the dehiscence por-
tion, even though the newly formed cementum and connec-
tive tissue regeneration was observed in the EMD group.
The periodontal interproximal defect used in this study can
be considered as a more unfavorable defect than a dehis-
cence or supraalveolar defect. Neither buccal nor lingual wall
is not present, and two opposing root surfaces lack vascular-
ization. Therefore, the periodontal interproximal defect can be
recognized as a defect without a bony wall.56) Since the com-
bination therapy in the supraalveolar and dehiscence defect
failed to show superior results over control, the more unfavor-
able defect can hardly exhibit better periodontal regeneration.
The combination therapy of BH and EMD provided the
promising results in several studies but on an inconsistent
basis. In vitro the combination of EMD with BH enhanced the
attachment, proliferation, and differentiation of periodontal lig-
ament cells and osteoblasts on BH particles.32) In the human
intrabony defects EMD showed the formation of connective
tissue attachment in human histologic analysis although the
configuration of the defect was not exactly specified.39) In
addition, several studies have supported that BH helps to aug-
ment the effect of EMDs in clinical attachment gain and prob-
ing depth reduction.33) On the contrary, other studies reported
that combination of EMD with BH failed to provide significant
differences compared with bovine bone material alone in
terms of attachment gain, probing depth, and BR37,40) in the
intrabony defects. 
This study reported the results using CBHA with EMD in the
periodontal interproximal without membrane. To improve the
result of combination therapy, further studies with barrier
membrane may be required. Animal studies presented com-
plete healing only when barrier membrane was applied regard-
less of application of EMD or BH.57) In the non-contained
defects, the combination of BH with a bilayered collagen bar-
rier demonstrated greater bone and cementum regeneration in
human radiographic and histologic analysis.58) Similar findings
have been reported by several studies.59,60) In a human clini-
cal study, EMD alone showed less probing depth reduction
and clinical attachment gain than guide tissue regeneration
using non-resorbable titanium-reinforced membrane in non-
contained defects.30) Therefore, application of barrier mem-
brane combined with EMD, BH and/or CBHA in the inter-
proximal periodontal defect model might result in better
results in radiographic or histologic analysis. 
Conclusion
Within the limitation of this study, EMD, CBHA, and combi-
nation of two materials showed similar periodontal regenera-
tion in the interproximal periodontal defect model. Further
investigation on combination with barrier membrane may be
required for improvement of the regenerative potential.
Figure 7. Residual material was color-coded into red-tone in
(a, b) CBHA group (c) EMD+CBHA group.
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